Extravasation of chemotherapy

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Extravasation of chemotherapy. / Langer, Seppo W.

I: Current Oncology Reports, Bind 12, Nr. 4, 07.2010, s. 242-6.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Langer, SW 2010, 'Extravasation of chemotherapy', Current Oncology Reports, bind 12, nr. 4, s. 242-6. https://doi.org/10.1007/s11912-010-0110-7

APA

Langer, S. W. (2010). Extravasation of chemotherapy. Current Oncology Reports, 12(4), 242-6. https://doi.org/10.1007/s11912-010-0110-7

Vancouver

Langer SW. Extravasation of chemotherapy. Current Oncology Reports. 2010 jul.;12(4):242-6. https://doi.org/10.1007/s11912-010-0110-7

Author

Langer, Seppo W. / Extravasation of chemotherapy. I: Current Oncology Reports. 2010 ; Bind 12, Nr. 4. s. 242-6.

Bibtex

@article{2e392260e25f4195bbc844466c497869,
title = "Extravasation of chemotherapy",
abstract = "Extravasation of chemotherapy is a feared complication of anticancer therapy. The accidental leakage of cytostatic agents into the perivascular tissues may have devastating short-term and long-term consequences for patients. In recent years, the increased focus on chemotherapy extravasation has led to the development of international guidelines that have proven useful tools in daily clinical practice. Moreover, the tissue destruction in one of the most dreaded types of extravasation (ie, anthracycline extravasation) now can effectively be prevented with a specific antidote, dexrazoxane.",
keywords = "Anthracyclines/adverse effects, Drug-Related Side Effects and Adverse Reactions, Extravasation of Diagnostic and Therapeutic Materials/prevention & control, Humans, Pharmaceutical Preparations/administration & dosage, Razoxane/therapeutic use, Treatment Outcome",
author = "Langer, {Seppo W}",
year = "2010",
month = jul,
doi = "10.1007/s11912-010-0110-7",
language = "English",
volume = "12",
pages = "242--6",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Extravasation of chemotherapy

AU - Langer, Seppo W

PY - 2010/7

Y1 - 2010/7

N2 - Extravasation of chemotherapy is a feared complication of anticancer therapy. The accidental leakage of cytostatic agents into the perivascular tissues may have devastating short-term and long-term consequences for patients. In recent years, the increased focus on chemotherapy extravasation has led to the development of international guidelines that have proven useful tools in daily clinical practice. Moreover, the tissue destruction in one of the most dreaded types of extravasation (ie, anthracycline extravasation) now can effectively be prevented with a specific antidote, dexrazoxane.

AB - Extravasation of chemotherapy is a feared complication of anticancer therapy. The accidental leakage of cytostatic agents into the perivascular tissues may have devastating short-term and long-term consequences for patients. In recent years, the increased focus on chemotherapy extravasation has led to the development of international guidelines that have proven useful tools in daily clinical practice. Moreover, the tissue destruction in one of the most dreaded types of extravasation (ie, anthracycline extravasation) now can effectively be prevented with a specific antidote, dexrazoxane.

KW - Anthracyclines/adverse effects

KW - Drug-Related Side Effects and Adverse Reactions

KW - Extravasation of Diagnostic and Therapeutic Materials/prevention & control

KW - Humans

KW - Pharmaceutical Preparations/administration & dosage

KW - Razoxane/therapeutic use

KW - Treatment Outcome

U2 - 10.1007/s11912-010-0110-7

DO - 10.1007/s11912-010-0110-7

M3 - Review

C2 - 20480268

VL - 12

SP - 242

EP - 246

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 4

ER -

ID: 247891221